Risk factor analysis for thrombotic microangiopathy after reduced-intensity or myeloablative allogeneic hematopoietic stem cell transplantation.

Source:http://linkedlifedata.com/resource/pubmed/id/16755559

Download in:

View as

General Info

PMID
16755559